Devonian Health Group Income Statement

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Revenue	18.52	23.59	19.31	2.35	2.31	1.47
Revenue Growth (YoY)	-23.01%	22.19%	723.15%	1.74%	56.32%	-31.19%
Cost of Revenue	11.41	15.03	11.83	1.45	1.74	1.72
Gross Profit	7.11	8.56	7.48	0.89	0.56	-0.24
Selling, General & Admin	6.81	7.2	6.68	3.75	2.58	1.45
Research & Development	1.97	2.01	1.29	1.35	0.78	0.61
Other Operating Expenses	0.13	0.13	0.12	0.12	0.11	-
Operating Expenses	8.91	9.33	8.09	5.22	3.47	2.07
Operating Income	-1.8	-0.77	-0.61	-4.32	-2.91	-2.31
Interest Expense	-0.13	-0.26	-0.44	-0.46	-0.94	-0.79
Interest & Investment Income	0.23	0.28	0.07	0.18	0.04	-
Other Non Operating Income (Expenses)	-	-	-	-	0.36	-0.29
EBT Excluding Unusual Items	-1.7	-0.75	-0.98	-4.6	-3.45	-3.39
Impairment of Goodwill	-4.64	-4.64	-	-	-	-
Asset Writedown	-0.2	-0.2	-	-	-	-
Other Unusual Items	-	-	-	-	-	0.05
Pretax Income	-6.54	-5.59	-0.98	-4.6	-3.45	-3.35
Income Tax Expense	0.42	0.42	0.85	-	-	-
Net Income	-6.97	-6.01	-1.83	-4.6	-3.45	-3.35
Net Income to Common	-6.97	-6.01	-1.83	-4.6	-3.45	-3.35
Shares Outstanding (Basic)	3	2	2	2	2	1
Shares Outstanding (Diluted)	3	2	2	2	2	1
Shares Change (YoY)	3.35%	0.76%	8.52%	13.89%	33.98%	22.70%
EPS (Basic)	-2.74	-2.43	-0.75	-2.04	-1.74	-2.26
EPS (Diluted)	-2.74	-2.43	-0.75	-2.04	-1.74	-2.28
Free Cash Flow	-6.22	-1.27	5.64	-4.36	-2.95	-1.83
Free Cash Flow Per Share	-2.44	-0.51	2.30	-1.93	-1.49	-1.24
Gross Margin	38.40%	36.28%	38.74%	38.05%	24.34%	-16.34%
Operating Margin	-9.70%	-3.27%	-3.18%	-184.37%	-126.35%	-156.37%
Profit Margin	-37.61%	-25.49%	-9.46%	-196.11%	-149.59%	-226.92%
Free Cash Flow Margin	-33.58%	-5.36%	29.20%	-185.74%	-127.77%	-124.31%
EBITDA	-1.54	-0.47	-0.22	-3.92	-2.07	-1.3
EBITDA Margin	-8.34%	-1.99%	-1.14%	-167.35%	-89.81%	-87.87%
D&A For EBITDA	0.25	0.3	0.39	0.4	0.84	1.01
EBIT	-1.8	-0.77	-0.61	-4.32	-2.91	-2.31
EBIT Margin	-9.70%	-3.27%	-3.18%	-184.37%	-126.35%	-156.37%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.